111 Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Buy
+3,730
New +$301K 0.05% 361
2025
Q4
Sell
-12,036
Closed -$1.15M 461
2025
Q3
$1.15M Buy
+12,036
New +$1.11M 0.22% 98
2025
Q2
Sell
-16,607
Closed -$1.49M 623
2025
Q1
$1.49M Buy
16,607
+5,106
+44% +$457K 0.29% 71
2024
Q4
$919K Buy
+11,501
New +$996K 0.19% 108

Other funds holding MDT

111 Capital's MDT Position: Q2 2026 in Review

111 Capital opened a new position in Medtronic (MDT) in Q2 2026: 3,730 shares worth $292K. The stake represents 0.05% of the portfolio and ranks #361 among its holdings. This is a return to the name: 111 Capital previously reported a position in MDT as recently as Q3 2025.

111 Capital first reported a position in MDT in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.49M in Q1 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • 111 Capital held 3,730 shares of Medtronic worth $292K as of Q2 2026.
  • Medtronic was a new 111 Capital position in Q2 2026.
  • Medtronic made up 0.05% of 111 Capital's portfolio in Q2 2026, its #361 holding.
  • 111 Capital first reported a position in Medtronic in Q4 2024 and has held it in 4 quarters since.
  • 111 Capital's Medtronic position peaked at $1.49M in Q1 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.